Saturday 17 October 2026
Export BIOX’s income statement to Excel — free account
Bioceres Crop Solutions Corp.
BIOX Basic Materials Agricultural Inputs
Bioceres Crop Solutions Corp.’s revenue for fiscal 2026 (year ended June 2026) was $238.2 million, down 28.6% from fiscal 2025. In the quarter to March 2026, revenue fell 34.7%, EPS fell 700.0%, free cash flow grew 344.3% and total debt fell 29.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.28
0.01
−3.45%
Follow BIOX
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 3 | — |
| (17.14%) | (17.77%) | (105.78%) | 0.00% | ||
| (6.86%) | (7.22%) | (34.33%) | (37.24%) | ||
ROIC |
(0.33%) | 0.40% | (1.21%) | (2.94%) | |
Return on Tangible Assets |
(123.42%) | (98.08%) | (896.25%) | (1,065.75%) | |
Average Days of Receivables |
200.89 | 203.51 | 215.25 | 202.97 | |
Free Cash Flow per Share |
0.70 | 0.85 | 1.24 | 0.00 | |
Free Cash Flow |
44.30 | 53.97 | 78.53 | — | |
Capital Expenditures |
(5.60) | (5.16) | (3.34) | — | |
| Other line items | |||||
Cash ROIC |
9.08% | 12.16% | 32.26% | 0.00% | |
Accounts Receivable Turnover |
1.63 | 1.60 | 1.40 | 1.52 | |
Accounts Payable Turnover |
1.53 | 1.54 | 1.53 | 1.62 | |
Inventory Turnover |
1.88 | 1.80 | 2.06 | 2.31 | |
Average Days of Payables |
173.03 | 185.76 | 182.50 | 172.14 | |
Days of Inventory on Hand |
161.47 | 175.84 | 137.07 | 114.18 | |
Tax Rate |
0.02 | 0.08 | 0.11 | 0.10 | |
Research and Development Expense of Revenue |
4.47% | 5.12% | 5.69% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
36.91% | 36.62% | 36.95% | 0.00% | |
Share Based Compensation of Revenue |
1.32% | 1.13% | 0.00% | 0.00% | |
Interest Coverage |
(0.04) | 0.04 | (0.07) | (0.15) | |
Operating CF/Net income |
(0.90) | (1.05) | (0.34) | 0.00 | |
Depreciation/Fixed assets |
0.30 | 0.31 | 0.37 | 0.00 | |
Capex/Depreciation |
(0.25) | (0.23) | (0.15) | — | |
Revenue per Share |
5.28 | 5.00 | 4.60 | 4.26 | |
Operating CF per Share |
0.79 | 0.93 | 1.29 | 0.00 | |
Capex per Share |
(0.09) | (0.08) | (0.05) | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.00 |
Columns are period end dates · fundamentals updated 2 Oct 2026